INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![Built for sites to benefit all]( "Built For Sites To Benefit All")
Built For Sites To Benefit AllThis one-minute video highlights the benefits of One Home for Sites. Join the movement to increase clinical trial capacity, because patients are waiting.
-
![Clinical Leader Solutions Expo]( "Top 3 Tips For Choosing The Right Oncology CRO")
Top 3 Tips For Choosing The Right Oncology CROFrom complex study designs and evolving regulations to time-sensitive treatment protocols, advancing oncology clinical trials present significant challenges for investigators, sites, and patients.
-
![GettyImages-1165109678-handshake-partner-business-agreement]( "8 Critical Questions To Ask Your IRB")
8 Critical Questions To Ask Your IRBThis article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.
-
![GettyImages-1433100886 budgeting]( "How ClinicReady Service's Supports Early-Stage Biotech Companies To Secure Funding")
How ClinicReady Service's Supports Early-Stage Biotech Companies To Secure FundingBy combining strategic foresight, operational efficiency, and financial incentives, Avance Clinical empowers biotech companies to navigate funding challenges and bring innovative therapies to market.
-
Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies8/29/2025
Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.
-
5 Questions That Put Sponsors Back in Control of Bioanalysis Projects12/9/2025
Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims; demand better technology, pricing transparency, and dedicated partnership.
-
From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined10/14/2025
Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.
-
How To Accelerate Early-Phase Oncology Trial5/12/2026
Purpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.
-
Effective Study Design And Execution Of Renal And Hepatic Impairment Trials5/1/2026
Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired populations.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-489341888 nurse clinical docs]( "Protocol-Driven, Customized Site Solution Strategy")
Accelerate study start-up with the right sites, patients, and partnerships
As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.
-
![Additional differentiators]( "Helping To Bring Hematologic Oncology Therapies To Cancer Patients")
Our mission is grounded in urgency and purpose: to shorten the time it takes for innovative blood cancer treatments to reach the patients and families who cannot afford to wait.
-
![oncology-trials-experts-GettyImages-2181815223]( "Oncology Clinical Trial Experts For Complex Trial Design")
Complex oncology trials require deep science, regulatory expertise, and coordination. See how integrated teams and adaptive designs speed startup, protect patients, and scale.
-
![GettyImages-1465572768 clinical site solution]( "A Definitive Guide To The Site Enablement Maturity Assessment")
Clinical research sites play a crucial role in data collection, patient interactions, and protocol procedures. Utilize this methodology for uncovering site enablement capability maturity.
-
![clinical-drug-development-GettyImages-1354172647]( "Drug Safety And Pharmacovigilance Services")
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
